Logos Global Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.65M | Buy |
850,000
+425,285
| +100% | +$2.33M | 0.51% | 36 |
|
|
2025
Q1 | $2.67M | Sell |
424,715
-825,285
| -66% | -$5.19M | 0.47% | 31 |
|
|
2024
Q4 | $5.15M | Sell |
1,250,000
-1,500,000
| -55% | -$6.18M | 0.6% | 36 |
|
|
2024
Q3 | $9.19M | Sell |
2,750,000
-50,000
| -2% | -$167K | 0.99% | 30 |
|
|
2024
Q2 | $8.34M | Buy |
2,800,000
+600,000
| +27% | +$1.79M | 0.67% | 34 |
|
|
2024
Q1 | $7.59M | Buy |
+2,200,000
| New | +$7.59M | 0.61% | 34 |
|